aluates Reports

$ 0.0

Automative

Global Antibody Based Therapeutics Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-6L16385

Global Antibody Based Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Antibody Based Therapeutics Market Research Report 2025

Code: QYRE-Auto-6L16385

Report

May 2025

Pages:91

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

Johnson & Johnson

Novartis

Gilead Sciences

Roche

Bristol–Myers Squibb

Amgen Inc

Astrazeneca plc

Merck

Takeda

Merck KGaA

Seagen

Eli Lilly

Ono Pharmaceutical

Pfizer Inc

Regeneron

Innovent

Hengrui Medicine

Antibody Based Therapeutics Market Size

The global market for Antibody Based Therapeutics was valued at US$ 213980 million in the year 2024 and is projected to reach a revised size of US$ 439860 million by 2031, growing at a CAGR of 11.0% during the forecast period.

Antibody Based Therapeutics Market

Therapeutic antibodies are drugs that use antibodies, one of the main players in our immune system inherent in our body. By making use of the specificity by which each antibody recognizes only one antigen, pinpointed attacks on specific antigens are possible.

The Therapeutic Antibodies Drug Market is driven by the remarkable potential of therapeutic antibodies to treat a diverse array of diseases, from cancer and autoimmune disorders to infectious diseases. Monoclonal antibodies have gained prominence as highly targeted and effective therapeutic agents that can modulate the immune system, neutralize pathogens, and inhibit disease-associated proteins. As precision medicine and biopharmaceutical innovations continue to advance, the demand for therapeutic antibodies grows. Innovations in antibody design, engineering, and manufacturing technologies further contribute to market expansion. Nevertheless, a significant challenge for this market is the need to address high production costs, optimize therapeutic antibody development processes, and navigate complex regulatory pathways while ensuring accessibility and affordability for patients. Overcoming manufacturing complexities, managing research and development costs, and addressing regulatory standards are ongoing challenges. Additionally, the market faces competition from small molecules and other biologic therapies, necessitating continuous research and development efforts to unlock the full therapeutic potential of therapeutic antibodies. Striking a balance between providing safe, effective, and accessible therapeutic antibody drugs while addressing scientific and regulatory challenges is essential for the continued growth of the Therapeutic Antibodies Drug Market.

This report aims to provide a comprehensive presentation of the global market for Antibody Based Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Based Therapeutics.

The Antibody Based Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antibody Based Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antibody Based Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Antibody Based Therapeutics Market Report

Report Metric	Details
Report Name	Antibody Based Therapeutics Market
Accounted market size in year	US$ 213980 million
Forecasted market size in 2031	US$ 439860 million
CAGR	11.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Monoclonal Antibodies Bi-Specific Antibodies Therapy Antibody-drug Conjugates Other
Segment by Application	Immune Diseases Cancer Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, Regeneron, Innovent, Hengrui Medicine
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Based Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Antibody Based Therapeutics Market growing?

Ans: The Antibody Based Therapeutics Market witnessing a CAGR of 11.0% during the forecast period 2025-2031.

What is the Antibody Based Therapeutics Market size in 2031?

Ans: The Antibody Based Therapeutics Market size in 2031 will be US$ 439860 million.

Who are the main players in the Antibody Based Therapeutics Market report?

Ans: The main players in the Antibody Based Therapeutics Market are AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, Regeneron, Innovent, Hengrui Medicine

What are the Application segmentation covered in the Antibody Based Therapeutics Market report?

Ans: The Applications covered in the Antibody Based Therapeutics Market report are Immune Diseases, Cancer, Other

What are the Type segmentation covered in the Antibody Based Therapeutics Market report?

Ans: The Types covered in the Antibody Based Therapeutics Market report are Monoclonal Antibodies, Bi-Specific Antibodies Therapy, Antibody-drug Conjugates, Other

Recommended Reports

Therapeutic Antibodies

Cancer Therapeutics

Autoimmune Diseases

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Antibody Based Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Monoclonal Antibodies

1.2.3 Bi-Specific Antibodies Therapy

1.2.4 Antibody-drug Conjugates

1.2.5 Other

1.3 Market by Application

1.3.1 Global Antibody Based Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Immune Diseases

1.3.3 Cancer

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Antibody Based Therapeutics Market Perspective (2020-2031)

2.2 Global Antibody Based Therapeutics Growth Trends by Region

2.2.1 Global Antibody Based Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Antibody Based Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Antibody Based Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Antibody Based Therapeutics Market Dynamics

2.3.1 Antibody Based Therapeutics Industry Trends

2.3.2 Antibody Based Therapeutics Market Drivers

2.3.3 Antibody Based Therapeutics Market Challenges

2.3.4 Antibody Based Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Antibody Based Therapeutics Players by Revenue

3.1.1 Global Top Antibody Based Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Antibody Based Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Antibody Based Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Antibody Based Therapeutics Revenue

3.4 Global Antibody Based Therapeutics Market Concentration Ratio

3.4.1 Global Antibody Based Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Antibody Based Therapeutics Revenue in 2024

3.5 Global Key Players of Antibody Based Therapeutics Head office and Area Served

3.6 Global Key Players of Antibody Based Therapeutics, Product and Application

3.7 Global Key Players of Antibody Based Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Antibody Based Therapeutics Breakdown Data by Type

4.1 Global Antibody Based Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Antibody Based Therapeutics Forecasted Market Size by Type (2026-2031)

5 Antibody Based Therapeutics Breakdown Data by Application

5.1 Global Antibody Based Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Antibody Based Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Antibody Based Therapeutics Market Size (2020-2031)

6.2 North America Antibody Based Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Antibody Based Therapeutics Market Size by Country (2020-2025)

6.4 North America Antibody Based Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Antibody Based Therapeutics Market Size (2020-2031)

7.2 Europe Antibody Based Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Antibody Based Therapeutics Market Size by Country (2020-2025)

7.4 Europe Antibody Based Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Antibody Based Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Antibody Based Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Antibody Based Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Antibody Based Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Antibody Based Therapeutics Market Size (2020-2031)

9.2 Latin America Antibody Based Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Antibody Based Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Antibody Based Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Antibody Based Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Antibody Based Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Antibody Based Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Antibody Based Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Antibody Based Therapeutics Introduction

11.1.4 AbbVie Revenue in Antibody Based Therapeutics Business (2020-2025)

11.1.5 AbbVie Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Antibody Based Therapeutics Introduction

11.2.4 Johnson & Johnson Revenue in Antibody Based Therapeutics Business (2020-2025)

11.2.5 Johnson & Johnson Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Antibody Based Therapeutics Introduction

11.3.4 Novartis Revenue in Antibody Based Therapeutics Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Gilead Sciences

11.4.1 Gilead Sciences Company Details

11.4.2 Gilead Sciences Business Overview

11.4.3 Gilead Sciences Antibody Based Therapeutics Introduction

11.4.4 Gilead Sciences Revenue in Antibody Based Therapeutics Business (2020-2025)

11.4.5 Gilead Sciences Recent Development

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Antibody Based Therapeutics Introduction

11.5.4 Roche Revenue in Antibody Based Therapeutics Business (2020-2025)

11.5.5 Roche Recent Development

11.6 Bristol-Myers Squibb

11.6.1 Bristol-Myers Squibb Company Details

11.6.2 Bristol-Myers Squibb Business Overview

11.6.3 Bristol-Myers Squibb Antibody Based Therapeutics Introduction

11.6.4 Bristol-Myers Squibb Revenue in Antibody Based Therapeutics Business (2020-2025)

11.6.5 Bristol-Myers Squibb Recent Development

11.7 Amgen

11.7.1 Amgen Company Details

11.7.2 Amgen Business Overview

11.7.3 Amgen Antibody Based Therapeutics Introduction

11.7.4 Amgen Revenue in Antibody Based Therapeutics Business (2020-2025)

11.7.5 Amgen Recent Development

11.8 AstraZeneca

11.8.1 AstraZeneca Company Details

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca Antibody Based Therapeutics Introduction

11.8.4 AstraZeneca Revenue in Antibody Based Therapeutics Business (2020-2025)

11.8.5 AstraZeneca Recent Development

11.9 Merck & Co

11.9.1 Merck & Co Company Details

11.9.2 Merck & Co Business Overview

11.9.3 Merck & Co Antibody Based Therapeutics Introduction

11.9.4 Merck & Co Revenue in Antibody Based Therapeutics Business (2020-2025)

11.9.5 Merck & Co Recent Development

11.10 Takeda

11.10.1 Takeda Company Details

11.10.2 Takeda Business Overview

11.10.3 Takeda Antibody Based Therapeutics Introduction

11.10.4 Takeda Revenue in Antibody Based Therapeutics Business (2020-2025)

11.10.5 Takeda Recent Development

11.11 Merck KGaA

11.11.1 Merck KGaA Company Details

11.11.2 Merck KGaA Business Overview

11.11.3 Merck KGaA Antibody Based Therapeutics Introduction

11.11.4 Merck KGaA Revenue in Antibody Based Therapeutics Business (2020-2025)

11.11.5 Merck KGaA Recent Development

11.12 Seagen

11.12.1 Seagen Company Details

11.12.2 Seagen Business Overview

11.12.3 Seagen Antibody Based Therapeutics Introduction

11.12.4 Seagen Revenue in Antibody Based Therapeutics Business (2020-2025)

11.12.5 Seagen Recent Development

11.13 Eli Lilly

11.13.1 Eli Lilly Company Details

11.13.2 Eli Lilly Business Overview

11.13.3 Eli Lilly Antibody Based Therapeutics Introduction

11.13.4 Eli Lilly Revenue in Antibody Based Therapeutics Business (2020-2025)

11.13.5 Eli Lilly Recent Development

11.14 Ono Pharmaceutical

11.14.1 Ono Pharmaceutical Company Details

11.14.2 Ono Pharmaceutical Business Overview

11.14.3 Ono Pharmaceutical Antibody Based Therapeutics Introduction

11.14.4 Ono Pharmaceutical Revenue in Antibody Based Therapeutics Business (2020-2025)

11.14.5 Ono Pharmaceutical Recent Development

11.15 Pfizer

11.15.1 Pfizer Company Details

11.15.2 Pfizer Business Overview

11.15.3 Pfizer Antibody Based Therapeutics Introduction

11.15.4 Pfizer Revenue in Antibody Based Therapeutics Business (2020-2025)

11.15.5 Pfizer Recent Development

11.16 Regeneron

11.16.1 Regeneron Company Details

11.16.2 Regeneron Business Overview

11.16.3 Regeneron Antibody Based Therapeutics Introduction

11.16.4 Regeneron Revenue in Antibody Based Therapeutics Business (2020-2025)

11.16.5 Regeneron Recent Development

11.17 Innovent

11.17.1 Innovent Company Details

11.17.2 Innovent Business Overview

11.17.3 Innovent Antibody Based Therapeutics Introduction

11.17.4 Innovent Revenue in Antibody Based Therapeutics Business (2020-2025)

11.17.5 Innovent Recent Development

11.18 Hengrui Medicine

11.18.1 Hengrui Medicine Company Details

11.18.2 Hengrui Medicine Business Overview

11.18.3 Hengrui Medicine Antibody Based Therapeutics Introduction

11.18.4 Hengrui Medicine Revenue in Antibody Based Therapeutics Business (2020-2025)

11.18.5 Hengrui Medicine Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

AbbVie

Johnson & Johnson

Novartis

Gilead Sciences

Roche

Bristol–Myers Squibb

Amgen Inc

Astrazeneca plc

Merck

Takeda

Merck KGaA

Seagen

Eli Lilly

Ono Pharmaceutical

Pfizer Inc

Regeneron

Innovent

Hengrui Medicine

List of Tables

Table 1. Global Antibody Based Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Monoclonal Antibodies

Table 3. Key Players of Bi-Specific Antibodies Therapy

Table 4. Key Players of Antibody-drug Conjugates

Table 5. Key Players of Other

Table 6. Global Antibody Based Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Antibody Based Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Antibody Based Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Antibody Based Therapeutics Market Share by Region (2020-2025)

Table 10. Global Antibody Based Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Antibody Based Therapeutics Market Share by Region (2026-2031)

Table 12. Antibody Based Therapeutics Market Trends

Table 13. Antibody Based Therapeutics Market Drivers

Table 14. Antibody Based Therapeutics Market Challenges

Table 15. Antibody Based Therapeutics Market Restraints

Table 16. Global Antibody Based Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Antibody Based Therapeutics Market Share by Players (2020-2025)

Table 18. Global Top Antibody Based Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Based Therapeutics as of 2024)

Table 19. Ranking of Global Top Antibody Based Therapeutics Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Antibody Based Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Antibody Based Therapeutics, Headquarters and Area Served

Table 22. Global Key Players of Antibody Based Therapeutics, Product and Application

Table 23. Global Key Players of Antibody Based Therapeutics, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Antibody Based Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Antibody Based Therapeutics Revenue Market Share by Type (2020-2025)

Table 27. Global Antibody Based Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Antibody Based Therapeutics Revenue Market Share by Type (2026-2031)

Table 29. Global Antibody Based Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Antibody Based Therapeutics Revenue Market Share by Application (2020-2025)

Table 31. Global Antibody Based Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Antibody Based Therapeutics Revenue Market Share by Application (2026-2031)

Table 33. North America Antibody Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Antibody Based Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Antibody Based Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Antibody Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Antibody Based Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Antibody Based Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Antibody Based Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Antibody Based Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Antibody Based Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Antibody Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Antibody Based Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Antibody Based Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Antibody Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Antibody Based Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Antibody Based Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 48. AbbVie Company Details

Table 49. AbbVie Business Overview

Table 50. AbbVie Antibody Based Therapeutics Product

Table 51. AbbVie Revenue in Antibody Based Therapeutics Business (2020-2025) & (US$ Million)

Table 52. AbbVie Recent Development

Table 53. Johnson & Johnson Company Details

Table 54. Johnson & Johnson Business Overview

Table 55. Johnson & Johnson Antibody Based Therapeutics Product

Table 56. Johnson & Johnson Revenue in Antibody Based Therapeutics Business (2020-2025) & (US$ Million)

Table 57. Johnson & Johnson Recent Development

Table 58. Novartis Company Details

Table 59. Novartis Business Overview

Table 60. Novartis Antibody Based Therapeutics Product

Table 61. Novartis Revenue in Antibody Based Therapeutics Business (2020-2025) & (US$ Million)

Table 62. Novartis Recent Development

Table 63. Gilead Sciences Company Details

Table 64. Gilead Sciences Business Overview

Table 65. Gilead Sciences Antibody Based Therapeutics Product

Table 66. Gilead Sciences Revenue in Antibody Based Therapeutics Business (2020-2025) & (US$ Million)

Table 67. Gilead Sciences Recent Development

Table 68. Roche Company Details

Table 69. Roche Business Overview

Table 70. Roche Antibody Based Therapeutics Product

Table 71. Roche Revenue in Antibody Based Therapeutics Business (2020-2025) & (US$ Million)

Table 72. Roche Recent Development

Table 73. Bristol-Myers Squibb Company Details

Table 74. Bristol-Myers Squibb Business Overview

Table 75. Bristol-Myers Squibb Antibody Based Therapeutics Product

Table 76. Bristol-Myers Squibb Revenue in Antibody Based Therapeutics Business (2020-2025) & (US$ Million)

Table 77. Bristol-Myers Squibb Recent Development

Table 78. Amgen Company Details

Table 79. Amgen Business Overview

Table 80. Amgen Antibody Based Therapeutics Product

Table 81. Amgen Revenue in Antibody Based Therapeutics Business (2020-2025) & (US$ Million)

Table 82. Amgen Recent Development

Table 83. AstraZeneca Company Details

Table 84. AstraZeneca Business Overview

Table 85. AstraZeneca Antibody Based Therapeutics Product

Table 86. AstraZeneca Revenue in Antibody Based Therapeutics Business (2020-2025) & (US$ Million)

Table 87. AstraZeneca Recent Development

Table 88. Merck & Co Company Details

Table 89. Merck & Co Business Overview

Table 90. Merck & Co Antibody Based Therapeutics Product

Table 91. Merck & Co Revenue in Antibody Based Therapeutics Business (2020-2025) & (US$ Million)

Table 92. Merck & Co Recent Development

Table 93. Takeda Company Details

Table 94. Takeda Business Overview

Table 95. Takeda Antibody Based Therapeutics Product

Table 96. Takeda Revenue in Antibody Based Therapeutics Business (2020-2025) & (US$ Million)

Table 97. Takeda Recent Development

Table 98. Merck KGaA Company Details

Table 99. Merck KGaA Business Overview

Table 100. Merck KGaA Antibody Based Therapeutics Product

Table 101. Merck KGaA Revenue in Antibody Based Therapeutics Business (2020-2025) & (US$ Million)

Table 102. Merck KGaA Recent Development

Table 103. Seagen Company Details

Table 104. Seagen Business Overview

Table 105. Seagen Antibody Based Therapeutics Product

Table 106. Seagen Revenue in Antibody Based Therapeutics Business (2020-2025) & (US$ Million)

Table 107. Seagen Recent Development

Table 108. Eli Lilly Company Details

Table 109. Eli Lilly Business Overview

Table 110. Eli Lilly Antibody Based Therapeutics Product

Table 111. Eli Lilly Revenue in Antibody Based Therapeutics Business (2020-2025) & (US$ Million)

Table 112. Eli Lilly Recent Development

Table 113. Ono Pharmaceutical Company Details

Table 114. Ono Pharmaceutical Business Overview

Table 115. Ono Pharmaceutical Antibody Based Therapeutics Product

Table 116. Ono Pharmaceutical Revenue in Antibody Based Therapeutics Business (2020-2025) & (US$ Million)

Table 117. Ono Pharmaceutical Recent Development

Table 118. Pfizer Company Details

Table 119. Pfizer Business Overview

Table 120. Pfizer Antibody Based Therapeutics Product

Table 121. Pfizer Revenue in Antibody Based Therapeutics Business (2020-2025) & (US$ Million)

Table 122. Pfizer Recent Development

Table 123. Regeneron Company Details

Table 124. Regeneron Business Overview

Table 125. Regeneron Antibody Based Therapeutics Product

Table 126. Regeneron Revenue in Antibody Based Therapeutics Business (2020-2025) & (US$ Million)

Table 127. Regeneron Recent Development

Table 128. Innovent Company Details

Table 129. Innovent Business Overview

Table 130. Innovent Antibody Based Therapeutics Product

Table 131. Innovent Revenue in Antibody Based Therapeutics Business (2020-2025) & (US$ Million)

Table 132. Innovent Recent Development

Table 133. Hengrui Medicine Company Details

Table 134. Hengrui Medicine Business Overview

Table 135. Hengrui Medicine Antibody Based Therapeutics Product

Table 136. Hengrui Medicine Revenue in Antibody Based Therapeutics Business (2020-2025) & (US$ Million)

Table 137. Hengrui Medicine Recent Development

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

Table 141. Authors List of This Report

List of Figures

Figure 1. Antibody Based Therapeutics Picture

Figure 2. Global Antibody Based Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Antibody Based Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Monoclonal Antibodies Features

Figure 5. Bi-Specific Antibodies Therapy Features

Figure 6. Antibody-drug Conjugates Features

Figure 7. Other Features

Figure 8. Global Antibody Based Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Antibody Based Therapeutics Market Share by Application: 2024 VS 2031

Figure 10. Immune Diseases Case Studies

Figure 11. Cancer Case Studies

Figure 12. Other Case Studies

Figure 13. Antibody Based Therapeutics Report Years Considered

Figure 14. Global Antibody Based Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Antibody Based Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Antibody Based Therapeutics Market Share by Region: 2024 VS 2031

Figure 17. Global Antibody Based Therapeutics Market Share by Players in 2024

Figure 18. Global Top Antibody Based Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Based Therapeutics as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Antibody Based Therapeutics Revenue in 2024

Figure 20. North America Antibody Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Antibody Based Therapeutics Market Share by Country (2020-2031)

Figure 22. United States Antibody Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Antibody Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Antibody Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Antibody Based Therapeutics Market Share by Country (2020-2031)

Figure 26. Germany Antibody Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Antibody Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Antibody Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Antibody Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Antibody Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Antibody Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Antibody Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Antibody Based Therapeutics Market Share by Region (2020-2031)

Figure 34. China Antibody Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Antibody Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Antibody Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Antibody Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Antibody Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Antibody Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Antibody Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Antibody Based Therapeutics Market Share by Country (2020-2031)

Figure 42. Mexico Antibody Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Antibody Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Antibody Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Antibody Based Therapeutics Market Share by Country (2020-2031)

Figure 46. Turkey Antibody Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Antibody Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Antibody Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. AbbVie Revenue Growth Rate in Antibody Based Therapeutics Business (2020-2025)

Figure 50. Johnson & Johnson Revenue Growth Rate in Antibody Based Therapeutics Business (2020-2025)

Figure 51. Novartis Revenue Growth Rate in Antibody Based Therapeutics Business (2020-2025)

Figure 52. Gilead Sciences Revenue Growth Rate in Antibody Based Therapeutics Business (2020-2025)

Figure 53. Roche Revenue Growth Rate in Antibody Based Therapeutics Business (2020-2025)

Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Antibody Based Therapeutics Business (2020-2025)

Figure 55. Amgen Revenue Growth Rate in Antibody Based Therapeutics Business (2020-2025)

Figure 56. AstraZeneca Revenue Growth Rate in Antibody Based Therapeutics Business (2020-2025)

Figure 57. Merck & Co Revenue Growth Rate in Antibody Based Therapeutics Business (2020-2025)

Figure 58. Takeda Revenue Growth Rate in Antibody Based Therapeutics Business (2020-2025)

Figure 59. Merck KGaA Revenue Growth Rate in Antibody Based Therapeutics Business (2020-2025)

Figure 60. Seagen Revenue Growth Rate in Antibody Based Therapeutics Business (2020-2025)

Figure 61. Eli Lilly Revenue Growth Rate in Antibody Based Therapeutics Business (2020-2025)

Figure 62. Ono Pharmaceutical Revenue Growth Rate in Antibody Based Therapeutics Business (2020-2025)

Figure 63. Pfizer Revenue Growth Rate in Antibody Based Therapeutics Business (2020-2025)

Figure 64. Regeneron Revenue Growth Rate in Antibody Based Therapeutics Business (2020-2025)

Figure 65. Innovent Revenue Growth Rate in Antibody Based Therapeutics Business (2020-2025)

Figure 66. Hengrui Medicine Revenue Growth Rate in Antibody Based Therapeutics Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Therapeutic Monoclonal Antibodies Drug Market Research Report 2024

Global Therapeutic Monoclonal Antibodies Market Research Report 2024

Global Research Area Antibodies Market Research Report 2025

Therapeutic Antibody Discovery Platform Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antibody Therapeutics and Blood Antibody Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Antibody Market Research Report 2025

Global Monoclonal Antibody Drugs for Cancer Market Research Report 2024

Global Immunoglobulin G Antibody Therapeutics Market Insights Forecast to 2030

Global BAG1 Antibody Market Research Report 2024

Global Next Generation Antibody Therapeutics Market Research Report 2025

B220 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Combination Antibody Therapy Market Research Report 2024

Global Nucleic acid based Therapeutics Drug Market Research Report 2024

Global Vectorized Antibodies Market Research Report 2025

Global Bcl 2 Antibody Market Research Report 2024

Global Next Generation Antibody Drug Market Research Report 2024

Global Immune Cell Therapy Drugs Market Research Report 2025

Antibody Drug Conjugate Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions